Proven innovation
AF Business Case
About
This business case has been created so that each organisation can assess the potential for improvements in the identification and management of Atrial Fibrillation (AF) in four key areas:
- Diagnosis of AF
- - Detection Gap
- Identification of those at high risk of stroke (CHA2DS2-VASc):
- - Protection Gap 1 (no risk assessment)
- Initiation of anticoagulant therapy in line with national guidelines
- - Protection Gap 2 (eligible and untreated)
- Maintenance of adequate anticoagulation:
- - Perfection Gap